These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22555270)

  • 1. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support.
    Goldstein DJ; Maybaum S; MacGillivray TE; Moore SA; Bogaev R; Farrar DJ; Frazier OH;
    J Card Fail; 2012 May; 18(5):392-5. PubMed ID: 22555270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
    Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
    Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience.
    Loforte A; Montalto A; Ranocchi F; Casali G; Luzi G; Monica PL; Sbaraglia F; Polizzi V; Distefano G; Musumeci F
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):765-71. PubMed ID: 19465866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Oliveira GH; Dupont M; Naftel D; Myers SL; Yuan Y; Tang WH; Gonzalez-Stawinski G; Young JB; Taylor DO; Starling RC
    J Am Coll Cardiol; 2014 Jan; 63(3):240-8. PubMed ID: 24161324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy.
    Boehmer JP; Starling RC; Cooper LT; Torre-Amione G; Wittstein I; Dec GW; Markham DW; Zucker MJ; Gorcsan J; McTiernan C; Kip K; McNamara DM;
    J Card Fail; 2012 Oct; 18(10):755-61. PubMed ID: 23040110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.
    Simon MA; Kormos RL; Murali S; Nair P; Heffernan M; Gorcsan J; Winowich S; McNamara DM
    Circulation; 2005 Aug; 112(9 Suppl):I32-6. PubMed ID: 16159839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of dilated cardiomyopathies in infants and children using left ventricular assist devices.
    Zimmerman H; Covington D; Smith R; Ihnat C; Barber B; Copeland J
    ASAIO J; 2010; 56(4):364-8. PubMed ID: 20559133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after left ventricular assist device with and without temporary right ventricular support.
    Lazar JF; Swartz MF; Schiralli MP; Schneider M; Pisula B; Hallinan W; Hicks GL; Massey HT
    Ann Thorac Surg; 2013 Dec; 96(6):2155-9. PubMed ID: 24035303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.
    Birks EJ; Drakos SG; Patel SR; Lowes BD; Selzman CH; Starling RC; Trivedi J; Slaughter MS; Alturi P; Goldstein D; Maybaum S; Um JY; Margulies KB; Stehlik J; Cunningham C; Farrar DJ; Rame JE
    Circulation; 2020 Nov; 142(21):2016-2028. PubMed ID: 33100036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.